Nordic Pharma Announces European Launch of Lacrifill® Canalicular Gel
-
February 10, 2026
-
2 min
February 10, 2026
Capital, innovation, and the next wave of ophthalmic breakthroughs
February 2, 2026
Three-session IPL strategy demonstrates stronger, longer-lasting gains for dry eye patients
by Alun Evans
January 13, 2026
This article will examine the indications, clinical evidence, and practical considerations for managing severe ocular surface disease and inflammatory dry eye using scleral lenses, and offer guidance to practitioners who seek to expand their therapeutic options.
May 1, 2026